Sera Prognostics Inc., a Salt Lake City-based company focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, has appointed Sandra A.J. Lawrence to its board of directors. Lawrence has served as trustee of the Delaware Funds by Macquarie, as a director of its New York and Australian Stock Exchange-listed close-end funds, and on its Audit and Investments committees since 2021. She has served as a trustee of its legacy Ivy and Waddell and Reed Mutual Funds Complex Trust, and on its Governance Committee, since 2019. Lawrence was the executive vice president and chief financial officer of Children’s Mercy Hospital from 2005 to 2016 and the executive vice president and chief administrative officer of Children’s Mercy Hospital from 2016 to February 2019. She was senior vice president and treasurer of Midwest Research Institute and subsequently its chief financial officer. Lawrence spent 26 years in professional or management positions in the architecture, real estate, investment banking, financial services, packaging and medical research industries. Lawrence also serves as a member of the board of directors of Evergy Inc., American Shared Hospital Services and Recology, and has been the chair of the board of directors of the Heartland Chapter of the National Association of Corporate Directors (NACD). She also serves on the boards of various charitable, nonprofit and civic organizations.